Since 1998, the Rehabilitation Clinical Trials Center (RCTC) at The Lundquist Institute has conducted cutting-edge clinical and translational research to improve the lives of patients with chronic lung diseases.
Our UCLA-affiliated research team, headed by Medical Directors Drs. Richard Casaburi and William Stringer, has pioneered new diagnostics, medications, devices and therapies to improve breathing, enhance exercise tolerance, promote physical activity and reduce exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).
Our center has published over 450 original research articles in leading medical journals on respiratory physiology and medicine, cardiopulmonary exercise testing, pulmonary rehabilitation and COPD.
Our research team is dedicated to improving exercise tolerance, physical activity and quality of life of patients living with chronic respiratory diseases.
Chronic Obstructive Pulmonary Disease (COPD) is a term that covers two common lung diseases:
It is estimated that over 13 million Americans have COPD. COPD is the third leading cause of death in the USA, and the fifth most common reason for being admitted to the hospital.
Watch our Medical Director, Dr. Richard Casaburi, and COPD patients speak on the American Health Journal about COPD, and how to treat symptoms using Pulmonary Rehabilitation: https://vimeo.com/123007786
Watch veteran newscaster and CBS Senior Contributor, Ted Koppel with his wife, Grace Anne, as they speak about COPD on the CBS Sunday Morning show (November 26, 2017): https://www.cbsnews.com/news/clearing-the-air-about-copd/
Please visit our event archive to see the previous events we have hosted.
The Rehabilitation Clinical Trials Center (RCTC) is located in the Chronic Disease Clinical Trials Center (CDCRC) Building at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, CA.
The CDCRC research facility was constructed in 2014 by a grant from the National Institutes of Health to house world-leading clinical research in chronic heart, lung and blood diseases.
The Lundquist Institute is an independent non-profit biomedical research organization that was founded in 1952. It is academically affiliated with the David Geffen School of Medicine at UCLA, and works in partnership with Harbor-UCLA Medical Center, a major academic teaching hospital serving over 700,000 residents in greater South Bay area of Los Angeles County.